| |
Patients with sinunasal tumors (n) |
Nasal tumors (%) |
Definitive RT (%) |
RT technique |
RT dose (Dose/fraction) (Gy) |
CTx (%) |
LC (%) |
OS (%) |
Cosmetic results |
| Combs et al. [9] |
46 |
16/46 (35) |
0 |
IMRT |
64 (2) |
0 |
49 (3yrs) |
90 (3yrs) |
n.a. |
| Daly et al. [10] |
36 |
7/36 (19) |
0 |
IMRT |
70 (2.12) |
17 |
58 (5yrs) |
45 (5yrs) |
n.a. |
| Hoppe et al. [15] |
85 |
24/85 (28) |
0 |
IMRT in 35% |
50-70 (1.8-2) |
2 |
87 (5yrs) |
67 (5yrs) |
n.a. |
| Madaniet al. [7] |
84 |
16/84 (19) |
11 |
IMRT |
70 (2) |
0 |
71 (5yrs) |
59 (5yrs) |
n.a. |
| Dirixet al. [11] |
40 |
6/40 (15) |
0 |
IMRT |
60/66 (2) |
0 |
76 (2yrs) |
89 (2yrs) |
n.a. |
| Duprezet al. [8] |
130 |
31/130 (24) |
22 |
IMRT |
70 (2) |
5 |
59 (5yrs) |
52 (5yrs) |
n.a. |
| Wiegner et al. [12] |
52 |
11/52 (21) |
9 |
IMRT |
66 (2.2) |
56 |
74 (2yrs) |
66 (2yrs) |
n.a. |
| Present study |
15 |
15/15 (100) |
47 |
IMRT |
|
53 |
87 (2yrs) |
100 (2yrs) |
69% excellent, 31% good |
| Total |
488 |
126 |
11 |
|
|
17 |
70 |
71 |
|
|
